Citadel Advisors’s Tuscan Holdings Corp. II Common Stock THCA Stock Holding History

Citadel Advisors’s Portfolio THCA Stock Details THCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-168,000	Closed	-$1.74M	–	14117
2022 Q2	$1.74M	Buy	168,000 +106,200	+172%	+$1.13M	﹤0.01%	5832
2022 Q1	$696K	Buy	61,800 +36,700	+146%	+$376K	﹤0.01%	8586
2021 Q4	$256K	Buy	25,100 +2,500	+11%	+$25.4K	﹤0.01%	11291
2021 Q3	$228K	Buy	22,600 +1,400	+7%	+$14.1K	﹤0.01%	11697
2021 Q2	$213K	Sell	21,200 -64,900	-75%	-$651K	﹤0.01%	12025
2021 Q1	$869K	Buy	+86,100	New	+$916K	﹤0.01%	8447

Citadel Advisors's THCA Position: Q3 2022 in Review

Citadel Advisors sold out of Tuscan Holdings Corp. II Common Stock (THCA) in Q3 2022, closing a stake of 21,431 shares — an estimated $222K sold.

Citadel Advisors first reported a position in THCA in Q1 2021 and held it in 4 quarters. The position peaked at $1.07M in Q1 2021. 16 funds tracked by Wall St. Rank hold THCA as of Q3 2022.

Citadel Advisors reported no remaining Tuscan Holdings Corp. II Common Stock position as of Q3 2022 after selling out during the quarter.
Citadel Advisors sold 21,431 Tuscan Holdings Corp. II Common Stock shares in Q3 2022, an estimated $222K.
Citadel Advisors first reported a position in Tuscan Holdings Corp. II Common Stock in Q1 2021 and held it in 4 quarters.
Citadel Advisors's Tuscan Holdings Corp. II Common Stock position peaked at $1.07M in Q1 2021.
16 funds tracked by Wall St. Rank held Tuscan Holdings Corp. II Common Stock as of Q3 2022.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.